This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Daily volatility informs risk tolerance and timing decisions. This overview highlights why investors should monitor volatility and adjust strategies.
28,131 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
A big stock move and a buyout rumor are reshaping how traders view NCR Atleos. A large block sale drew attention, jus...
Turning Point Brands stock has surged, even as a prominent fund dumped millions in TPB shares. This article breaks do...
SpaceX often grabs headlines, but the case for buying stock today isn’t as clear-cut. Here are three solid cautions t...
Lucid Group has faced years of volatility, but Saudi backing and a clearer product roadmap could shift the odds. This...
As 2026 looms, investors hunt for clarity in a volatile crypto landscape. From ETH buy-ins by top analysts to evolvin...
Nuclear energy is a long game for investors. This guide weighs NuScale Power against Oklo as a path to exposure in th...
Roundhill’s WEEK ETF is gaining attention for delivering regular weekly distributions from short-term U.S. Treasuries...
When an energy storage company reports stronger results, the market often reacts with a sharp stock move. This guide ...
SpaceX has been a marquee name in tech and defense circles. If spacex down from all-time high, investors should analy...
March 2026 brings a crowded field of Seeking Alpha alternatives. Traders now weigh real-time data, crowd insights, an...
The Arizona project marks a major test of brand-led real estate funding through Regulation A+. With a minimum $500 in...